2,6-Bis[(2H7)-2-propanyl](O-2H4)phenol

Names

[ Name ]:
2,6-Bis[(2H7)-2-propanyl](O-2H4)phenol

[Synonym ]:
2,6-Bis[(H)-2-propanyl](O-H)phenol
Propofol-d18
2,6-Bis[(H)propan-2-yl](O-H)phenol
2,5-ANHYDRO-2,5-IMINO-D-MANNITOL HYDROCHLORIDE
Phenol-3,4,5-d-d, 2,6-bis[1-(methyl-d)ethyl-1,2,2,2-d]-

Chemical & Physical Properties

[ Density]:
0.9±0.1 g/cm3

[ Boiling Point ]:
256.0±0.0 °C at 760 mmHg

[ Molecular Formula ]:
C₁₂D₁₈O

[ Molecular Weight ]:
196.382

[ Flash Point ]:
107.5±7.2 °C

[ Exact Mass ]:
196.248749

[ PSA ]:
20.23000

[ LogP ]:
4.16

[ Vapour Pressure ]:
0.0±0.5 mmHg at 25°C

[ Index of Refraction ]:
1.513

MSDS

Click to get detail MSDS

Safety Information

[ Symbol ]:

GHS02, GHS06, GHS08

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H225-H301 + H311 + H331-H370

[ Precautionary Statements ]:
P210-P260-P280-P301 + P310-P311

[ RIDADR ]:
UN1230 - class 3 - PG 2 - Methanol, solution

Articles

WIN OVER study: Efficacy and safety of olmesartan in Indian hypertensive patients: results of an open label, non-comparative, multi-centric, post marketing observational study.

Indian Heart J. 66(3) , 340-344, (2014)

Hypertension is a global health problem. Multiple classes of drugs including angiotensin receptor blockers (ARBs) are available for the treatment of hypertension. Olmesartan is a relatively newer ARB ...

Feasibility of cisplatin/5-fluorouracil and panitumumab in Japanese patients with squamous cell carcinoma of the head and neck.

Jpn. J. Clin. Oncol. , (2014)

In Japan, cisplatin/5-fluorouracil 80/800 (cisplatin 80 mg/m2, 5-fluorouracil 800 mg/m2) is widely used to treat recurrent/metastatic squamous cell carcinoma of the head and neck, whereas cisplatin/5-...

Population pharmacokinetic-pharmacodynamic modelling of mycophenolic acid in paediatric renal transplant recipients in the early post-transplant period.

Br. J. Clin. Pharmacol. , doi:10.1111/bcp.12426, (2014)

The purpose of this study was to develop a population pharmacokinetic and pharmacodynamic (PK-PD) model for mycophenolic acid (MPA) in paediatric renal transplant recipients in the early post-transpla...